Literature DB >> 25684872

Successful induction of granulomatosis with polyangiitis with tacrolimus.

R Ramachandran1, S Tiwana2, D Prabhakar1, K Gowda3, R Nada3, V Kumar1, M Rathi1, H S Kohli1, V Jha1, K L Gupta1, V Sakhuja1.   

Abstract

We report a 50-year-old female who presented with inflammatory arthritis, upper respiratory tract symptoms, and microscopic hematuria with nephrotic range proteinuria. Antineutrophil cytoplasmic antibodies (ANCA) were detectable and kidney biopsy showed pauci-immune focal necrotizing crescentic glomerulonephritis. She was treated with pulse intravenous cyclophosphamide (CYC) and prednisolone. Patient developed severe leucopenia after the first dose and subsequently had leucopenia to low dose CYC, mycophenolate mofetil and azathioprine were also tried. However, patient developed leukopenia with all the above agents. Initiation of tacrolimus (TAC) was followed by dramatic response: Proteinuria decreased, serum albumin normalized and C-ANCA and anti-PR3 ANCA assays became negative. This is the first successful case of TAC as an induction agent in a patient with GPA (ANCA associated vasculitis with renal involvement).

Entities:  

Keywords:  Antineutrophil cytoplasmic antibodies; associated vasculitis; granulomatosis with polyangiitis

Year:  2015        PMID: 25684872      PMCID: PMC4323912          DOI: 10.4103/0971-4065.136885

Source DB:  PubMed          Journal:  Indian J Nephrol        ISSN: 0971-4065


  14 in total

1.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

2.  Azathioprine-induced leukopenia--clinical significance in renal transplantation.

Authors:  R Pollak; R A Nishikawa; M F Mozes; O Jonasson
Journal:  J Surg Res       Date:  1980-09       Impact factor: 2.192

Review 3.  Small-vessel vasculitis.

Authors:  J C Jennette; R J Falk
Journal:  N Engl J Med       Date:  1997-11-20       Impact factor: 91.245

4.  Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis.

Authors:  Xiao Li; Hong Ren; Qianying Zhang; Wen Zhang; Xiaojing Wu; Yaowen Xu; Pingyan Shen; Nan Chen
Journal:  Nephrol Dial Transplant       Date:  2011-09-13       Impact factor: 5.992

5.  Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Authors:  Susan L Hogan; Ronald J Falk; Hyunsook Chin; Jianwen Cai; Caroline E Jennette; J Charles Jennette; Patrick H Nachman
Journal:  Ann Intern Med       Date:  2005-11-01       Impact factor: 25.391

6.  Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients.

Authors:  Wilhelm H Schmitt; E Christiaan Hagen; Irmgard Neumann; Rainer Nowack; Luis Felipe Flores-Suárez; Fokko J van der Woude
Journal:  Kidney Int       Date:  2004-04       Impact factor: 10.612

7.  Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

Authors:  Kirsten de Groot; Lorraine Harper; David R W Jayne; Luis Felipe Flores Suarez; Gina Gregorini; Wolfgang L Gross; Rashid Luqmani; Charles D Pusey; Niels Rasmussen; Renato A Sinico; Vladimir Tesar; Philippe Vanhille; Kerstin Westman; Caroline O S Savage
Journal:  Ann Intern Med       Date:  2009-05-19       Impact factor: 25.391

8.  Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement.

Authors:  Weixin Hu; Chunbei Liu; Honglang Xie; Huiping Chen; Zhihong Liu; Leishi Li
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

Review 9.  Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Authors:  C Mukhtyar; O Flossmann; B Hellmich; P Bacon; M Cid; J W Cohen-Tervaert; W L Gross; L Guillevin; D Jayne; A Mahr; P A Merkel; H Raspe; D Scott; J Witter; H Yazici; R A Luqmani
Journal:  Ann Rheum Dis       Date:  2007-10-02       Impact factor: 19.103

10.  Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression.

Authors:  M Gera; M D Griffin; U Specks; N Leung; M D Stegall; F C Fervenza
Journal:  Kidney Int       Date:  2007-04-04       Impact factor: 10.612

View more
  1 in total

Review 1.  Recent advances in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  B Lazarus; G T John; C O'Callaghan; D Ranganathan
Journal:  Indian J Nephrol       Date:  2016 Mar-Apr
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.